|Last Price||Today's Change||52-Week Range||Trading Volume|
|57.98||0.43 (+0.75%)||52.49 - 63.62||6.8 million (Below Avg)|
Market data as of 3:42PM 07/07/15. Quotes are delayed by at least 15 min.
Remedy Pharmaceuticals Expands Its Board in Anticipation of Stroke Trial Results
07/07/2015 9:00 AM ET
Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint in Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
06/29/2015 8:30 AM ET